Adaptable Intranasal Pain Relief Systems for Niche Environments
Legal Citation
Summary of the Inventive Concept
A family of portable, preservative-free intranasal composition spray systems designed for specific, high-need markets, such as disaster relief, high-security, emergency response, remote areas, and extreme weather conditions.
Background and Problem Solved
The original patent disclosed a preservative-free intranasal composition for treating various pain conditions. However, the original formulation and device were not adapted for use in extreme or specialized environments. This inventive concept addresses the need for adaptable, reliable, and effective pain relief solutions in niche markets.
Detailed Description of the Inventive Concept
The new inventive concept comprises a range of systems, each tailored to a specific operational environment. For disaster relief, a portable, lightweight spray container is designed for easy transport and use in extreme weather conditions. For high-security needs, a secure, tamper-evident spray device ensures the composition is administered safely and securely. For emergency response situations, a handheld intranasal spray device with a mechanical pump is optimized for high-stress environments. For remote, hard-to-reach areas, a solar-powered mechanical pump device enables reliable operation. Finally, for extreme cold weather conditions, a thermally-insulated spray device maintains the composition's efficacy.
Novelty and Inventive Step
The new claims introduce novel adaptations of the original preservative-free intranasal composition for specific, high-need markets. The inventive step lies in the tailored design of each system to address the unique challenges and constraints of its respective operational environment.
Alternative Embodiments and Variations
Alternative embodiments may include variations in spray container materials, mechanical pump designs, or thermally-insulated devices. Additional variations could include integration with wearable devices or telemedicine platforms to enhance patient monitoring and treatment.
Potential Commercial Applications and Market
The adaptable intranasal pain relief systems have significant commercial potential in various industries, including disaster relief, high-security, emergency response, remote healthcare, and extreme weather operations. The market demand for effective, reliable, and specialized pain relief solutions in these niches is substantial, and this inventive concept is well-positioned to capitalize on these opportunities.
CPC Classifications
| Section | Class | Group |
|---|---|---|
| A | A61 | A61K31/167 |
| A | A61 | A61K9/0043 |
| A | A61 | A61M11/00 |
| A | A61 | A61M2210/0618 |
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Medical Device Design and Pharmaceutical Formulation, specifically intranasal drug delivery systems for pain management, involving expertise in pharmacology, mechanical engineering, and medical device design
Person of Ordinary Skill (PHOSITA) Profile
A professional with advanced degrees in pharmaceutical sciences or biomedical engineering, experienced in drug delivery system design, familiar with medical device adaptations for specialized environments, and knowledgeable about preservative-free formulation techniques
Obviousness Rationale
A PHOSITA would recognize that the PTD represents predictable variations of the source patent's core technology by applying standard design adaptation techniques to the preservative-free intranasal lidocaine composition. The disclosed environmental modifications represent routine engineering problem-solving for specialized medical device deployment. The fundamental therapeutic mechanism and chemical composition remain substantially unchanged, with variations focused on mechanical and contextual delivery adaptations.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,520 |
|---|---|
| Title | Therapeutic composition of intranasal lidocaine |
| Assignee(s) | Nortic Holdings Inc. |